Code Clarity
S7 E1: How Theramex walked away from PMCPA jurisdiction and what it means for pharma self-regulation
5:21
Theramex is the third UK pharma company to leave PMCPA jurisdiction in three years (Sandoz 2023, Evolus 2024, Theramex 2026).
Does that reflect increasing rules, companies avoiding audit, or self-regulation management of issues?
Rina & Jean discuss how we got here and what it means for the future of self-regulation.